The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. 2007

Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
Department of Pathophysiology, Medical University of Silesia in Katowice, ul. Medyków 18, 40-752 Katowice, Poland. holomed@poczta.onet.pl

OBJECTIVE To assess the influence of weight reduction therapy on serum osteoprotegerin (OPG) concentration in obese patients and compare these results with normal-weight controls. METHODS Forty-three obese women (BMI, 36.7 +/- 4.1 kg/m2; mean age, 50.1 +/- 4.5 years) were studied. The control group consisted of 19 normal-weight women (BMI, 24.2 +/- 2.1 kg/m2; mean age, 53.8 +/- 5.2 years). In all patients, serum concentrations of OPG, C telopeptide of type I collagen containing the cross-linking site (CTX), osteocalcin, parathormone, 25-(OH)-D3 (vitamin D), and total calcium and phosphorus were assessed before and after a 3-month weight reduction therapy. RESULTS In obese subjects, serum concentrations of OPG, 25-(OH)-D3, osteocalcin, total calcium, and phosphorus were significantly lower, and serum concentration of parathormone was significantly higher, before weight reduction therapy in comparison with normal-weight controls. After weight reduction, a significantly higher serum concentration of 25-(OH)-D3 and CTX and significantly lower concentration of OPG were found. CONCLUSIONS Serum concentration of OPG was significantly lower in obese patients in comparison with normal-weight controls. Weight reduction therapy resulted in further decrease in OPG serum concentrations. Therefore, OPG cannot be treated as a protective factor from bone loss in obese patients.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014965 X-Rays Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard X-rays are the higher energy, shorter wavelength X-rays. Soft x-rays or Grenz rays are less energetic and longer in wavelength. The short wavelength end of the X-ray spectrum overlaps the GAMMA RAYS wavelength range. The distinction between gamma rays and X-rays is based on their radiation source. Grenz Ray,Grenz Rays,Roentgen Ray,Roentgen Rays,X Ray,X-Ray,Xray,Radiation, X,X-Radiation,Xrays,Ray, Grenz,Ray, Roentgen,Ray, X,Rays, Grenz,Rays, Roentgen,Rays, X,X Radiation,X Rays,X-Radiations

Related Publications

Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
July 2015, Journal of clinical nursing,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
February 2005, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
January 1992, Annals of nutrition & metabolism,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
June 1999, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
April 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
July 2009, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
June 1985, Psychological reports,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
December 2014, Respiratory physiology & neurobiology,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
November 1953, The New England journal of medicine,
Michał Holecki, and Barbara Zahorska-Markiewicz, and Joanna Janowska, and Teresa Nieszporek, and Katarzyna Wojaczyńska-Stanek, and Agnieszka Zak-Gołab, and Andrzej Wiecek
January 1985, American journal of obstetrics and gynecology,
Copied contents to your clipboard!